What is a prescribing cascade?
A prescribing cascade is what happens when a side effect of one medication is mistaken for a new illness and treated with a second medication, whose side effects are mistaken for a third illness and treated again. Nobody plans one, and each step looks reasonable at the time.
Long-term benzodiazepine use is a reliable place for a cascade to begin, because the drug’s later effects look so much like other diseases. Clorazepate, sold as Tranxene, produces a slow and quiet version of the pattern. So, how does one prescription turn into four, and how do you get the chain to stop?
Why is clorazepate so hard to see through?
Clorazepate is a prodrug: the tablet you swallow is not the active drug. Once swallowed, it is quickly converted, by a reaction the label calls decarboxylation, into nordiazepam, also known as desmethyldiazepam.
The Ashton Manual, in Chapter I, Table 1, lists the half-life of clorazepate’s active metabolite at 36 to 200 hours, and the drug’s own label gives nordiazepam an apparent half-life of about 40 to 50 hours and says it shows moderate accumulation with repeated dosing. As a result, levels build for weeks after daily dosing starts and fall just as slowly when a dose is lowered.
An analogy that might help is a bathtub with a partly open drain. Open the tap a little and the water rises for a long time before it settles, and close it a little and it drops just as slowly. While this is not a perfect analogy, it explains why you can feel worse three weeks after a change you have already stopped thinking about, and why a reduction should be judged weeks later, not the next morning.
Your anxiety got worse on a steady dose. Is that the drug?
Many people on a long-term benzodiazepine find that anxiety creeps back after years on the same dose, sometimes with tremor, tingling, a pounding heart, or panic that never happened before. The Ashton Manual’s Chapter I section on tolerance describes exactly this: as the brain adapts, withdrawal symptoms can emerge even while the drug is still being taken.
Physical dependence is not addiction. A person who took clorazepate as prescribed for ten years has a body that adapted to it, a medical condition caused by the prescription, and that adaptation produces these symptoms.
Unfortunately, the usual response is more treatment: a higher benzodiazepine dose, a selective serotonin reuptake inhibitor (SSRI), or an antipsychotic. While any of these may bring a few weeks of relief, the tolerance pattern tends to return at the new level, and nobody asked whether the anxiety was the drug’s own effect.
You are tired and flat, and someone called it depression.
Long-acting benzodiazepine metabolites cause daytime drowsiness and slowed thinking, and on clorazepate that sedation is steady rather than in waves. Too often, it gets relabeled as fatigue or depression and treated with an antidepressant, occasionally a stimulant, while the benzodiazepine’s share goes unexamined.
People who have taken a benzodiazepine for years also describe a narrowed emotional range, which Professor C. Heather Ashton called “emotional anaesthesia” in Chapter I of the Ashton Manual, and a doctor can read that flatness as anxiety under control. Emotional blunting on Klonopin follows the same shape, and the same misreading.
Low mood still deserves to be taken seriously. If you are having thoughts of harming yourself, call or text 988, the Suicide and Crisis Lifeline, or go to an emergency department, and let the drug question wait.
Your memory is slipping, and the word dementia came up.
The Ashton Manual notes that complete tolerance to the effects on memory and cognition does not seem to occur, and that in older people benzodiazepines can produce confusion, unsteadiness, and what Chapter I calls “pseudodementia.” In a younger person the same fog gets worked up as attention deficit hyperactivity disorder (ADHD), with a stimulant to follow, and in an older person as early dementia.
Fortunately, this impairment is often at least partly reversible once the drug is slowly reduced, which makes either label costly. A workup that never asks what you have been taking for a decade can miss the one reversible cause on the list.
You cannot sleep, so a second sedative was added.
Benzodiazepines taken during the day can disturb sleep at night, especially once tolerance to the sedative effect has set in, and the complaint that follows is insomnia. The common answer is a second sedating drug on top of the first, whether quetiapine, trazodone, or zolpidem, and now you take two sedatives with overlapping risks.
If the sleeping pill helps for a while and then stops, that is the same tolerance pattern arriving on the second drug. Before a third is added, the older prescription is the one to ask about.
Falls, an irritable streak, and a racing heart each got their own workup.
Oversedation is more marked in older people and, as the Ashton Manual puts it, may contribute to falls and fractures. When a fall is treated as a bone problem and nobody reviews the medication list, the drug that caused the fall stays on the list.
Rarely, a patient becomes irritable, impulsive, or agitated on a benzodiazepine, which the clorazepate label calls a paradoxical or disinhibitory reaction and which the Ashton Manual says is most frequent in older people and children. Read as new bipolar disorder or a personality problem, the change earns a mood stabilizer or an antipsychotic, and the cause is never named.
Gut and autonomic symptoms do the same. Constipation, reflux, palpitations, temperature swings, and dizziness on standing can appear during long-term use, and each can generate its own specialist, testing, and drug. Dysautonomia after long-term benzodiazepine use deserves the drug question before the testing begins.
None of this means every new symptom is the benzodiazepine. Chest pain, a seizure, fainting, sudden loss of vision or hearing, new weakness on one side, or a fall with a blow to the head are emergencies that need 911 or an emergency department, whatever list you are on.
Why does this keep happening to careful doctors?
Of course, prescribing cascades come from how medical care is arranged, far more than from careless doctors. Visits are short, specialists work in silos, and the fastest path out of a short visit is a new prescription.
Electronic records list recent additions at the top and old renewals at the bottom, and a prescription refilled every ninety days for ten years stops looking like a decision and starts looking like furniture. And, when a patient suggests the old prescription as the cause, the reply is often reassurance rather than a review. Yet, this is not a plea against doctors, most of whom were never taught about tolerance and work in a system that pays for additions, not subtractions.
How do you interrupt a cascade?
The first move is a question, asked before any new prescription: could this be the drug? For any new symptom on a long-term benzodiazepine, the medication list, with start dates and past dose changes, is the first thing to check.
The second move is to consider a reduction before an addition. If the new symptom might be tolerance, sedation, or disinhibition, a slow, small dose reduction made with your prescriber tells you more than a new drug would, because the symptom either eases or does not. Both the Ashton Manual and the Maudsley Deprescribing Guidelines describe such symptoms being mistaken for the original condition or a new illness, and this step follows from that, though neither states it as a rule.
A reduction is never the same as stopping. Since the 2020 United States Food and Drug Administration (FDA) label update, clorazepate carries a boxed warning that abrupt discontinuation or rapid dosage reduction can precipitate acute withdrawal reactions that can be life-threatening, and the label names seizures among them and calls for a gradual taper. The pace is between you and your doctor, with you directing the speed as tolerated.
The third move is a standing review of every chronic medication at a visit set aside for it. How often that would catch a cascade is not a number this article can give you, only a pattern that doctors who taper these drugs see often, and experience varies.
What is different when the drug is clorazepate?
Clorazepate’s wrinkle is that nordiazepam builds and clears so slowly that its sedation and fog develop over weeks and outlast any single dose, which makes them hard to connect to the tablet. The effect of lowering it may not be fully visible for two to three weeks, so reductions are usually made less often than with a short-acting benzodiazepine, and each is judged with patience.
Dr. Leeds’ view, shared by the sources this site cites, is that the reduction is small, slow, and patient directed. On clorazepate that patience matters twice over, because the drug’s own timetable is slow.
A composite pattern: a patient in their sixties on clorazepate for years is seen for tiredness and started on an antidepressant, then for poor sleep and given a sleeping pill, then for confusion and sent for a memory workup. Nobody on that chain had a reason to pull the first prescription forward. The patient’s own question, at the fourth visit, finally did.
What happens when you ask the question yourself?
You are allowed to ask whether an old prescription could be causing a new symptom, and to ask again if the first answer is reassurance. Bring the whole list, with dates, and ask your doctor to look at it with you before the next addition.
Still, time is on your side once the drug question is in play. Sedation, fog, and flatness from a long-acting benzodiazepine tend to lift as the level comes down over the weeks the drug takes to leave, and whatever remains is a shorter, more honest list to bring back to your doctor.
This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.